Metraipolis › archive › dc_f8316f66e69a

HR+/HER2- breast cancer brain metastases treated with definitive local therapy: a focus on endocrine sensitivity and incidence of leptomeningeal disease — Europe PMC PMID:41938756

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41938756
DOI
10.1093/noajnl/vdag048
License (as archived)
solo-consultazione
Archived
2026-11-07T03:32:47.167Z
SHA-256 of the archived text
425d12443b01ac4e8cedfde4f5876925c062b1ec26fccfc091a80051d4debbb4
Stable URL of this page
https://metraipolis.com/documento/dc_f8316f66e69a

How to cite

HR+/HER2- breast cancer brain metastases treated with definitive local therapy: a focus on endocrine sensitivity and incidence of leptomeningeal disease — Europe PMC PMID:41938756 — Europe PMC (en), https://europepmc.org/article/MED/41938756 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f8316f66e69a (Metraipolis archive dc_f8316f66e69a, sha256 425d12443b01ac4e8cedfde4f5876925c062b1ec26fccfc091a80051d4debbb4)
BibTeX
@misc{dcf8316f66e69a,
  title = {HR+/HER2- breast cancer brain metastases treated with definitive local therapy: a focus on endocrine sensitivity and incidence of leptomeningeal disease — Europe PMC PMID:41938756},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41938756},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f8316f66e69a; sha256 425d12443b01ac4e8cedfde4f5876925c062b1ec26fccfc091a80051d4debbb4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41938756. Agents can read the archived copy with the MCP tool read_document.